TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 1 filers reported holding TANGO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $990 | +429.4% | 87,882 | +56.2% | 0.00% | – |
| Q2 2023 | $187 | -20.4% | 56,264 | -5.5% | 0.00% | – |
| Q1 2023 | $235 | -60.8% | 59,529 | -27.9% | 0.00% | – |
| Q4 2022 | $599 | -99.9% | 82,522 | -31.1% | 0.00% | – |
| Q3 2022 | $433,000 | -31.2% | 119,715 | -13.8% | 0.00% | – |
| Q2 2022 | $629,000 | -32.5% | 138,836 | +13.0% | 0.00% | -100.0% |
| Q1 2022 | $932,000 | – | 122,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $146,779,000 | 53.77% |
| TCG Crossover Management, LLC | 1,254,500 | $9,509,000 | 3.82% |
| Cormorant Asset Management, LP | 4,899,185 | $37,136,000 | 2.85% |
| Boxer Capital, LLC | 6,871,642 | $52,087,000 | 2.68% |
| Casdin Capital, LLC | 5,487,910 | $41,598,000 | 1.86% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $14,567,000 | 1.42% |
| Samsara BioCapital, LLC | 630,000 | $4,775,000 | 1.20% |
| TANG CAPITAL MANAGEMENT LLC | 468,750 | $3,553,000 | 0.71% |
| Southpoint Capital Advisors LP | 3,805,929 | $28,849,000 | 0.56% |
| HARVARD MANAGEMENT CO INC | 708,385 | $5,370,000 | 0.54% |